Viatris (VTRS) Change in Inventory (2020 - 2026)
Viatris (VTRS) posted Change in Inventory of $99.5 million for Q2 2026, down 19.11% on a QoQ basis from $123.0 million in Q1 2026, and up 155.13% year-over-year from $39.0 million in Q2 2025.
Analysis
Viatris (VTRS) Change in Inventory (2020 - 2026) Analysis & Trends
Viatris has reported Change in Inventory for 7 years, with the latest figure at $99.5 million in Q2 2026.
- On a quarterly basis, Change in Inventory rose 155.13% year-over-year to $99.5 million in Q2 2026; TTM through Jun 2026 was $96.2 million, a 75.79% decrease from a year earlier, with the FY2025 full-year figure at $106.4 million, down 85.29% from the prior year.
- Change in Inventory was $99.5 million for Q2 2026 at Viatris, down from $123.0 million in the prior quarter.
- The five-year high for Change in Inventory was $370.4 million in Q1 2024, with the low at -$180.1 million in Q4 2022.
- Average Change in Inventory over 5 years is $107.0 million, with a median of $125.3 million recorded in 2023.
- The largest YoY upside for Change in Inventory was 1578.22% in 2022 against a maximum downside of 335.42% in 2022.
- Over 5 years, Change in Inventory stood at -$180.1 million in 2022, then surged by 170.85% to $127.6 million in 2023, then tumbled by 72.1% to $35.6 million in 2024, then plunged by 144.38% to -$15.8 million in 2025, then soared by 729.75% to $99.5 million in 2026.
- The last three Change in Inventory figures came in at $99.5 million (Q2 2026), $123.0 million (Q1 2026), and -$15.8 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.33 Bn | 38.68 Bn | 2.15 Bn | -59.00 Mn |
| 2 | Viatris | 19.05 Bn | 18.16 Bn | 1.46 Bn | 99.50 Mn |
| 3 | Dr Reddys Laboratories | 9.76 Bn | 9.58 Bn | 396.53 Mn | -76.69 Mn |
| 4 | Amneal Pharmaceuticals | 5.38 Bn | 5.25 Bn | 334.51 Mn | 69.19 Mn |
| 5 | Bausch Health Companies | 2.27 Bn | 436.38 Mn | 2.10 Bn | 22.00 Mn |
| 6 | Alvotech | 1.51 Bn | 1.37 Bn | 2.56 Mn | -403,000.00 |
| 7 | Ani Pharmaceuticals | 1.51 Bn | 1.15 Bn | 165.89 Mn | -305,000.00 |
| 8 | Amphastar Pharmaceuticals | 1.03 Bn | 737.26 Mn | 93.47 Mn | 9.88 Mn |
| 9 | Fennec Pharmaceuticals | 393.12 Mn | 351.87 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 171.02 Mn | 171.02 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 99.50 Mn |
| Mar 31, 2026 | 123.00 Mn |
| Dec 31, 2025 | -15.80 Mn |
| Sep 30, 2025 | -110.50 Mn |
| Jun 30, 2025 | 39.00 Mn |
| Mar 31, 2025 | 193.70 Mn |
| Dec 31, 2024 | 35.60 Mn |
| Sep 30, 2024 | 129.00 Mn |
| Jun 30, 2024 | 188.40 Mn |
| Mar 31, 2024 | 370.40 Mn |
| Dec 31, 2023 | 127.60 Mn |
| Sep 30, 2023 | 219.20 Mn |
| Jun 30, 2023 | 115.40 Mn |
| Mar 31, 2023 | 151.10 Mn |
| Dec 31, 2022 | -180.10 Mn |
| Sep 30, 2022 | 169.50 Mn |
| Jun 30, 2022 | 201.00 Mn |
| Mar 31, 2022 | 69.10 Mn |
| Dec 31, 2021 | 76.50 Mn |
| Sep 30, 2021 | 10.10 Mn |